ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

IKNA Ikena Oncology Inc

1.41
0.10 (7.63%)
시간외 거래
최종 업데이트: 05:42:21
15분 지연
기업명 주식 심볼 시장 주식 타입
Ikena Oncology Inc IKNA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.10 7.63% 1.41 05:42:21
개장가 저가 고가 종가 전일 종가
1.32 1.3109 1.43 1.41 1.31
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/04/202421:00GLOBEIkena Oncology to Present at the Stifel 2024 Virtual..
12/03/202421:00GLOBEIkena Oncology Reports Fourth Quarter and Full Year 2023..
06/03/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/02/202422:00GLOBEIkena Oncology to Participate in TD Cowen 44th Annual Health..
22/02/202406:29EDGAR2Form 8-K - Current report
22/02/202406:15GLOBEIkena Oncology Appoints Caroline Germa, M.D. as Chief..
03/02/202407:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202407:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202406:26EDGAR2Form 8-K - Current report
19/01/202406:05GLOBEIkena Oncology Outlines Key Priorities and Provides..
09/11/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:09EDGAR2Form 8-K - Current report
09/11/202321:00GLOBEIkena Oncology Shares Initial Positive and Differentiated..
07/11/202322:00GLOBEIkena Oncology to Present at Multiple November 2023 Investor..
12/10/202306:10EDGAR2Form 8-K - Current report
26/09/202305:05EDGAR2Form DEF 14A - Other definitive proxy statements
16/09/202305:05EDGAR2Form PRE 14A - Other preliminary proxy statements
13/09/202305:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/09/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
05/09/202321:00GLOBEIkena Oncology to Participate in September 2023 Investor..
19/08/202305:02EDGAR2Form S-3 - Registration statement under Securities Act of..
10/08/202321:00GLOBEIkena Oncology Reports Second Quarter 2023 Financial Results..
10/08/202320:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/08/202321:02EDGAR2Form 8-K - Current report
07/08/202320:00GLOBEIkena Oncology Acquires Pionyr Immunotherapeutics in..
01/07/202306:15EDGAR2Form 8-K - Current report
24/05/202321:00GLOBEIkena Oncology to Participate in Upcoming Investor..
15/05/202320:50GLOBEIkena Oncology Reports First Quarter 2023 Financial Results..
15/05/202320:45GLOBEIkena Oncology Announces $40 Million Underwritten Offering

최근 히스토리

Delayed Upgrade Clock